Stocks and Investing Stocks and Investing
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018

Alethia Young Maintained (ASND) at Buy with Increased Target to $78 on, Mar 20th, 2018


Published on 2024-10-26 03:57:07 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $50 to $78 on, Mar 20th, 2018.

Alethia has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $60 on, Thursday, January 25th, 2018

Contributing Sources